Isogenica, specialists in the discovery and optimisation of therapeutic and diagnostic peptides, proteins and antibodies and Aston University have secured funding from the Technology Strategy Board (TSB), the UK’s innovation agency, for a £0.5M project to develop a gene library assembly technology exclusively licensed to Isogenica.
The funding enables Isogenica to develop a robust, automated manufacturing process for the commercial synthesis of ratio controlled gene libraries using a patent protected methodology invented by Dr Anna Hine and her team at Aston University. The capability to build high quality libraries has application in antibody, protein scaffold and peptide discovery, where high integrity libraries can be designed and built that will increase library diversity and maximise the probability of finding good quality leads.
“Isogenica has been approached on a number of occasions by customers interested in accessing controlled ratio controlled libraries and for screening libraries using our proprietary CIS Display technology. We have an exclusive license to Aston University’s innovative technology and will develop the approach to meet the market needs for rapid, high quality gene libraries and we hope to launch this product area within the next 6 months” said Kevin Mathews, CEO of Isogenica.
To find out more about how your organisation can benefit from Aston’s academic expertise, contact the Business Partnership Team on 0121 204 4242 or email firstname.lastname@example.org.